{"entity":{"type":"insider","cik":"0001623108","url":"/insider/0001623108","json_url":"/insider/0001623108.json","name":"Frenkel Ran","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2015-04-08","last":"2022-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Frenkel Ran","source":"filing","n_filings":10,"first_seen":"2015-04-08","last_seen":"2022-03-02"}],"transactions":[{"id":6542446,"accession":"0001209191-22-014629","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-014629","line_url":"/filing/0001209191-22-014629#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (EVP, Chief Dev. Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1663.0,"shares_display":"1,663","price_per_share":10.2376,"price_display":"10.24","price_state":"stated","total_value":17025.1288,"total_display":"17,025.13","total_whole":"17,025","shares_owned_after":168290.0,"shares_owned_after_display":"168,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":6565538,"accession":"0001209191-22-011643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011643","line_url":"/filing/0001209191-22-011643#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (EVP, Chief Dev. Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2929.0,"shares_display":"2,929","price_per_share":12.1234,"price_display":"12.12","price_state":"stated","total_value":35509.4386,"total_display":"35,509.44","total_whole":"35,509","shares_owned_after":101703.0,"shares_owned_after_display":"101,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-22","scope":"insider"},{"id":6722606,"accession":"0001209191-22-008128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008128","line_url":"/filing/0001209191-22-008128#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (EVP, Chief Dev. Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1991.0,"shares_display":"1,991","price_per_share":9.862,"price_display":"9.86","price_state":"stated","total_value":19635.242,"total_display":"19,635.24","total_whole":"19,635","shares_owned_after":104632.0,"shares_owned_after_display":"104,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider"},{"id":4177246,"accession":"0001209191-21-012967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012967","line_url":"/filing/0001209191-21-012967#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (EVP, Chief Dev. Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2887.0,"shares_display":"2,887","price_per_share":14.8312,"price_display":"14.83","price_state":"stated","total_value":42817.6744,"total_display":"42,817.67","total_whole":"42,818","shares_owned_after":46126.0,"shares_owned_after_display":"46,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-22","scope":"insider"},{"id":5422872,"accession":"0001209191-21-011490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011490","line_url":"/filing/0001209191-21-011490#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (EVP, Chief Dev. Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2046.0,"shares_display":"2,046","price_per_share":15.519,"price_display":"15.52","price_state":"stated","total_value":31751.874,"total_display":"31,751.87","total_whole":"31,752","shares_owned_after":39338.0,"shares_owned_after_display":"39,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-17","scope":"insider"},{"id":2831710,"accession":"0001209191-20-028271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-028271","line_url":"/filing/0001209191-20-028271#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (Chief Dev Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1974.0,"shares_display":"1,974","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":39480.0,"total_display":"39,480.00","total_whole":"39,480","shares_owned_after":35088.0,"shares_owned_after_display":"35,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-11","scope":"insider"},{"id":2433930,"accession":"0001209191-20-011696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-011696","line_url":"/filing/0001209191-20-011696#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (Chief Dev Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2975.0,"shares_display":"2,975","price_per_share":16.4819,"price_display":"16.48","price_state":"stated","total_value":49033.6525,"total_display":"49,033.65","total_whole":"49,034","shares_owned_after":36066.0,"shares_owned_after_display":"36,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-21","scope":"insider"},{"id":4833409,"accession":"0001209191-17-059945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-059945","line_url":"/filing/0001209191-17-059945#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (Chief Dev Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4958.0,"shares_display":"4,958","price_per_share":11.2455,"price_display":"11.25","price_state":"stated","total_value":55755.189,"total_display":"55,755.19","total_whole":"55,755","shares_owned_after":24733.0,"shares_owned_after_display":"24,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-07","filed_date":"2017-11-09","scope":"insider"},{"id":3004086,"accession":"0001209191-16-150139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-150139","line_url":"/filing/0001209191-16-150139#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (Chief Dev Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev Operations Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3309.0,"shares_display":"3,309","price_per_share":10.0593,"price_display":"10.06","price_state":"stated","total_value":33286.2237,"total_display":"33,286.22","total_whole":"33,286","shares_owned_after":14691.0,"shares_owned_after_display":"14,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-15","scope":"insider"},{"id":8598731,"accession":"0001209191-15-033114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-033114","line_url":"/filing/0001209191-15-033114#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (EVP, WW Development Operations)","role_mark":"O","role_mark_label":"Officer (EVP, WW Development Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, WW Development Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":66000.0,"total_display":"66,000.00","total_whole":"66,000","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-07","filed_date":"2015-04-08","scope":"insider"},{"id":8598727,"accession":"0001209191-15-033114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-033114","line_url":"/filing/0001209191-15-033114#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001623108","owner_name":"Frenkel Ran","owner_display_name":"Frenkel Ran","owner_url":"/insider/0001623108","role":"Officer (EVP, WW Development Operations)","role_mark":"O","role_mark_label":"Officer (EVP, WW Development Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, WW Development Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":29.43,"price_display":"29.43","price_state":"stated","total_value":29430.0,"total_display":"29,430.00","total_whole":"29,430","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-06","filed_date":"2015-04-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (EVP, Chief Dev. Officer)","n_filings":10,"first_seen":"2015-04-08","last_seen":"2022-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001623108","retrieved_at":"2026-08-26T18:57:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}